• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

培哚普利叔丁胺盐与黄芪丹参汤联合通过沉默信息调节因子3/线粒体动力学途径预防慢性肾脏病

Combination of Perindopril Erbumine and Huangqi-Danshen Decoction Protects Against Chronic Kidney Disease via Sirtuin3/Mitochondrial Dynamics Pathway.

作者信息

Wei Xian, Wang Yuzhi, Weng Jiali, Lao Yunlan, Deng Ruyu, Lu Jiandong, Yang Shudong, Liu Xinhui

机构信息

Department of Nephrology, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen 518000, China.

The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen 518000, Guangdong, China.

出版信息

Evid Based Complement Alternat Med. 2022 May 21;2022:5812105. doi: 10.1155/2022/5812105. eCollection 2022.

DOI:10.1155/2022/5812105
PMID:35677375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9170396/
Abstract

BACKGROUND

Chronic kidney disease (CKD) is a major public health problem worldwide. Treatment with renin-angiotensin system inhibitors can achieve only partial efficacy on renal function decline and renal fibrosis in CKD patients. Huangqi-Danshen decoction (HDD) is a basic Chinese herbal pair which is commonly used to treat CKD with good efficacy.

OBJECTIVES

The current study aimed to investigate the effect of perindopril erbumine (PE), an angiotensin-converting enzyme inhibitor, combined with HDD on adenine-induced CKD rat model and explore the possible mechanism from Sirtuin3/mitochondrial dynamics pathway.

METHOD

CKD rat model was established by feeding of 0.75% w/w adenine containing diet for 3 weeks. At the same time, the treatment groups were given PE (0.42 mg/kg/d) or HDD (4.7 g/kg/d) or PE combined with HDD by gavage for 4 weeks. Renal function was evaluated by the levels of serum creatinine (Scr) and blood urea nitrogen (BUN). The renal pathological injury was observed by periodic acid-Schiff (PAS) and Masson's trichrome staining. Proteins expression was determined by Western blot analysis. Mitochondrial morphology was observed by transmission electron microscopy.

RESULTS

PE in combination with HDD significantly improved renal function, reduced tubular injury and interstitial fibrosis in adenine-induced CKD rats. Moreover, PE + HDD treatment mainly activated the Sirtuin3 expression level. In addition, PE + HDD exhibited bidirectional regulation on mitochondrial dynamics by suppressing mitochondrial fission protein dynaminrelated protein 1 expression and elevating mitochondrial fusion protein optic atrophy 1 expression, resulted in restraint of mitochondrial fragmentation.

CONCLUSION

The combination of PE and HDD attenuated adenine-induced CKD in rats, which was possibly associated with Sirtuin3/mitochondrial dynamics pathway.

摘要

背景

慢性肾脏病(CKD)是全球主要的公共卫生问题。肾素 - 血管紧张素系统抑制剂治疗CKD患者时,在肾功能下降和肾纤维化方面仅能取得部分疗效。黄芪 - 丹参汤(HDD)是常用的治疗CKD的基础中药药对,疗效良好。

目的

本研究旨在探讨血管紧张素转换酶抑制剂培哚普利叔丁胺盐(PE)联合HDD对腺嘌呤诱导的CKD大鼠模型的影响,并从沉默信息调节因子3/线粒体动力学途径探索其可能机制。

方法

通过喂养含0.75%(w/w)腺嘌呤的饮食3周建立CKD大鼠模型。同时,治疗组通过灌胃给予PE(0.42mg/kg/d)或HDD(4.7g/kg/d)或PE联合HDD,持续4周。通过血清肌酐(Scr)和血尿素氮(BUN)水平评估肾功能。通过高碘酸 - 希夫(PAS)染色和Masson三色染色观察肾脏病理损伤。通过蛋白质印迹分析确定蛋白质表达。通过透射电子显微镜观察线粒体形态。

结果

PE联合HDD可显著改善腺嘌呤诱导的CKD大鼠的肾功能,减轻肾小管损伤和间质纤维化。此外,PE + HDD治疗主要激活了沉默信息调节因子3的表达水平。此外,PE + HDD通过抑制线粒体分裂蛋白动力相关蛋白1的表达和提高线粒体融合蛋白视神经萎缩蛋白1的表达,对线粒体动力学表现出双向调节作用,从而抑制线粒体碎片化。

结论

PE与HDD联合使用可减轻腺嘌呤诱导的大鼠CKD,这可能与沉默信息调节因子3/线粒体动力学途径有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392b/9170396/7819f5cbdb0b/ECAM2022-5812105.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392b/9170396/619dcee46b30/ECAM2022-5812105.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392b/9170396/ad887b2283d4/ECAM2022-5812105.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392b/9170396/c1ce74a20978/ECAM2022-5812105.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392b/9170396/edba9284c3a9/ECAM2022-5812105.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392b/9170396/964fbfb36120/ECAM2022-5812105.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392b/9170396/7819f5cbdb0b/ECAM2022-5812105.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392b/9170396/619dcee46b30/ECAM2022-5812105.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392b/9170396/ad887b2283d4/ECAM2022-5812105.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392b/9170396/c1ce74a20978/ECAM2022-5812105.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392b/9170396/edba9284c3a9/ECAM2022-5812105.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392b/9170396/964fbfb36120/ECAM2022-5812105.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/392b/9170396/7819f5cbdb0b/ECAM2022-5812105.006.jpg

相似文献

1
Combination of Perindopril Erbumine and Huangqi-Danshen Decoction Protects Against Chronic Kidney Disease via Sirtuin3/Mitochondrial Dynamics Pathway.培哚普利叔丁胺盐与黄芪丹参汤联合通过沉默信息调节因子3/线粒体动力学途径预防慢性肾脏病
Evid Based Complement Alternat Med. 2022 May 21;2022:5812105. doi: 10.1155/2022/5812105. eCollection 2022.
2
Huangqi-Danshen Decoction Ameliorates Adenine-Induced Chronic Kidney Disease by Modulating Mitochondrial Dynamics.黄芪丹参汤通过调节线粒体动力学改善腺嘌呤诱导的慢性肾脏病
Evid Based Complement Alternat Med. 2019 Jan 1;2019:9574045. doi: 10.1155/2019/9574045. eCollection 2019.
3
Jian-Pi-Yi-Shen formula enhances perindopril inhibition of chronic kidney disease progression by activation of SIRT3, modulation of mitochondrial dynamics, and antioxidant effects.健脾益肾方通过激活 SIRT3、调节线粒体动力学和抗氧化作用增强了培哚普利抑制慢性肾脏病进展的作用。
Biosci Rep. 2021 Oct 29;41(10). doi: 10.1042/BSR20211598.
4
Huangqi-Danshen decoction reshapes renal glucose metabolism profiles that delays chronic kidney disease progression.黄芪-丹参汤重塑肾脏糖代谢谱延缓慢性肾脏病进展。
Biomed Pharmacother. 2023 Aug;164:114989. doi: 10.1016/j.biopha.2023.114989. Epub 2023 Jun 13.
5
Metabolomics Analysis Reveals the Protection Mechanism of Huangqi-Danshen Decoction on Adenine-Induced Chronic Kidney Disease in Rats.代谢组学分析揭示黄芪丹参汤对腺嘌呤诱导的大鼠慢性肾脏病的保护机制。
Front Pharmacol. 2019 Sep 10;10:992. doi: 10.3389/fphar.2019.00992. eCollection 2019.
6
Jian-Pi-Yi-Shen Formula Alleviates Chronic Kidney Disease in Two Rat Models by Modulating QPRT/NAD/SIRT3/Mitochondrial Dynamics Pathway.健脾益肾方通过调节QPRT/NAD/SIRT3/线粒体动力学途径减轻两种大鼠模型的慢性肾脏病
Evid Based Complement Alternat Med. 2021 Dec 13;2021:6625345. doi: 10.1155/2021/6625345. eCollection 2021.
7
Effects of honokiol protects against chronic kidney disease via BNIP3/NIX and FUNDC1-mediated mitophagy and AMPK pathways.和厚朴酚通过 BNIP3/NIX 和 FUNDC1 介导的线粒体自噬和 AMPK 通路对慢性肾脏病的保护作用。
Mol Biol Rep. 2023 Aug;50(8):6557-6568. doi: 10.1007/s11033-023-08592-1. Epub 2023 Jun 20.
8
Huangqi-Danshen decoction protects against cisplatin-induced acute kidney injury in mice.黄芪丹参汤对顺铂诱导的小鼠急性肾损伤具有保护作用。
Front Pharmacol. 2023 Nov 16;14:1236820. doi: 10.3389/fphar.2023.1236820. eCollection 2023.
9
Huangqi-Danshen decoction alleviates diabetic nephropathy in mice by inhibiting PINK1/Parkin-mediated mitophagy.黄芪丹参汤通过抑制PINK1/Parkin介导的线粒体自噬减轻小鼠糖尿病肾病。
Am J Transl Res. 2020 Mar 15;12(3):989-998. eCollection 2020.
10
Lipidomics reveals the potential mechanism of honokiol against adenine-induced chronic kidney disease.脂质组学揭示厚朴酚抗腺嘌呤诱导的慢性肾脏病的潜在机制。
Front Pharmacol. 2022 Oct 14;13:1019629. doi: 10.3389/fphar.2022.1019629. eCollection 2022.

引用本文的文献

1
Natural products in traditional Chinese medicine for renal fibrosis: a comprehensive review.用于肾纤维化的中药天然产物:综述
Front Pharmacol. 2025 Apr 16;16:1560567. doi: 10.3389/fphar.2025.1560567. eCollection 2025.
2
Huangqi-Danshen Decoction Against Renal Fibrosis in UUO Mice via TGF-β1 Induced Downstream Signaling Pathway.黄芪丹参汤通过 TGF-β1 诱导的下游信号通路防治 UUO 小鼠肾纤维化。
Drug Des Devel Ther. 2024 Sep 14;18:4119-4134. doi: 10.2147/DDDT.S457100. eCollection 2024.
3
Biomarker identification and pathway analysis of and couplet medicines on adenine-induced chronic kidney disease in rats based on metabolomics.

本文引用的文献

1
SIRT3 deficiency exacerbates early-stage fibrosis after ischaemia-reperfusion-induced AKI.沉默调节蛋白3(SIRT3)缺乏会加剧缺血再灌注诱导的急性肾损伤(AKI)后的早期纤维化。
Cell Signal. 2022 May;93:110284. doi: 10.1016/j.cellsig.2022.110284. Epub 2022 Feb 16.
2
The Use of Chinese Yang/Qi-Invigorating Tonic Botanical Drugs/Herbal Formulations in Ameliorating Chronic Kidney Disease by Enhancing Mitochondrial Function.使用中国补气壮阳滋补植物药/草药配方通过增强线粒体功能改善慢性肾脏病
Front Pharmacol. 2021 Jun 24;12:622498. doi: 10.3389/fphar.2021.622498. eCollection 2021.
3
Chronic kidney disease.
基于代谢组学的对药对腺嘌呤诱导的大鼠慢性肾脏病的生物标志物鉴定及通路分析
Front Pharmacol. 2023 Apr 6;14:1103527. doi: 10.3389/fphar.2023.1103527. eCollection 2023.
慢性肾脏病。
Lancet. 2021 Aug 28;398(10302):786-802. doi: 10.1016/S0140-6736(21)00519-5. Epub 2021 Jun 24.
4
Mitochondrial fusion and fission: The fine-tune balance for cellular homeostasis.线粒体融合与裂变:细胞动态平衡的精细调节。
FASEB J. 2021 Jun;35(6):e21620. doi: 10.1096/fj.202100067R.
5
Mitochondrial SIRT3 confers neuroprotection in Huntington's disease by regulation of oxidative challenges and mitochondrial dynamics.线粒体 SIRT3 通过调节氧化应激和线粒体动态平衡赋予亨廷顿病的神经保护作用。
Free Radic Biol Med. 2021 Feb 1;163:163-179. doi: 10.1016/j.freeradbiomed.2020.11.031. Epub 2020 Dec 4.
6
Sustainable Development Goals relevant to kidney health: an update on progress.与肾脏健康相关的可持续发展目标:进展情况更新。
Nat Rev Nephrol. 2021 Jan;17(1):15-32. doi: 10.1038/s41581-020-00363-6. Epub 2020 Nov 13.
7
Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target.线粒体 Sirtuin 3:新出现的生物学功能和治疗靶点。
Theranostics. 2020 Jul 9;10(18):8315-8342. doi: 10.7150/thno.45922. eCollection 2020.
8
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家慢性肾脏病负担,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
9
Yiqihuoxue Formula Activates Autophagy and Offers Renoprotection in a Rat Model of Adenine-Induced Kidney Disease.益气活血方激活自噬并对腺嘌呤诱导的大鼠肾病模型提供肾脏保护作用。
Evid Based Complement Alternat Med. 2019 Dec 24;2019:3423981. doi: 10.1155/2019/3423981. eCollection 2019.
10
Mitochondrial Dynamics and Its Involvement in Disease.线粒体动态及其与疾病的关系。
Annu Rev Pathol. 2020 Jan 24;15:235-259. doi: 10.1146/annurev-pathmechdis-012419-032711. Epub 2019 Oct 4.